Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
出版年份 2017 全文链接
标题
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 41, Pages E8685-E8694
出版商
Proceedings of the National Academy of Sciences
发表日期
2017-10-03
DOI
10.1073/pnas.1701821114
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance
- (2016) Luis Manso et al. PLoS One
- Beta 1-integrin–c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes
- (2016) Rachel Barrow-McGee et al. Nature Communications
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Metal ion and ligand binding of integrin α5β1
- (2014) Wei Xia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma
- (2013) W. S. Carbonell et al. CANCER RESEARCH
- Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance
- (2013) A. Jahangiri et al. CLINICAL CANCER RESEARCH
- Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model
- (2013) Parul Gupta et al. PLoS One
- Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
- (2012) Yao Dai et al. BMC CANCER
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
- (2012) Kan V. Lu et al. CANCER CELL
- Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy
- (2012) M. DeLay et al. CLINICAL CANCER RESEARCH
- Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor
- (2012) Masamichi Nagae et al. JOURNAL OF CELL BIOLOGY
- High-Dose Antiangiogenic Therapy for Glioblastoma: Less May Be More?
- (2011) J. F. de Groot CLINICAL CANCER RESEARCH
- Quantitative proteomics of the integrin adhesome show a myosin II-dependent recruitment of LIM domain proteins
- (2011) Herbert B Schiller et al. EMBO REPORTS
- Biochemical, Proteomic, Structural, and Thermodynamic Characterizations of Integrin-linked Kinase (ILK)
- (2011) Koichi Fukuda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis for Selective Small Molecule Kinase Inhibition of Activated c-Met
- (2011) Keith W. Rickert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neurosurgical Management and Prognosis of Patients With Glioblastoma That Progresses During Bevacizumab Treatment
- (2011) Aaron J. Clark et al. NEUROSURGERY
- Integrin-linked kinase: Not so ‘pseudo’ after all
- (2011) G E Hannigan et al. ONCOGENE
- Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of Caveolae
- (2010) Sara A. Wickström et al. DEVELOPMENTAL CELL
- Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
- (2010) Gur Pines et al. FEBS LETTERS
- Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
- (2010) A K Mitra et al. ONCOGENE
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- The Vascular Basement Membrane as “Soil” in Brain Metastasis
- (2009) W. Shawn Carbonell et al. PLoS One
- 1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
- (2008) C. C. Park et al. CANCER RESEARCH
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of Vascular Endothelial Growth Factor 189 in Breast Cancer Cells Leads to Delayed Tumor Uptake with Dilated Intratumoral Vessels
- (2007) Marie-Astrid Hervé et al. AMERICAN JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started